Date: 2023-07-09 12:42 pm (UTC)
redbird: closeup of me drinking tea, in a friend's kitchen (Default)
From: [personal profile] redbird
That Alzheimer's drug link is a press release from 2019. I couldn't find anything really promising about that drug published in the last couple of years, unfortunately.

The results the company is claiming in that press release are at least comparable to the anti-amyloid monoclonal antibody drug that the United States has approved. That sounds better than it is, though--the monoclonal was approved based on a "surrogate endpoint," meaning that the lab results improved but the patients may or may not have.

Given the amount of fraud and wishful thinking in Alzheimer's research in the last 20 year, including some of the major papers on amyloid beta, a drug that targets something else sounds like a good idea, but they've had four years to publish a research paper about the claims in that press release.

Date: 2023-07-09 07:26 pm (UTC)
agoodwinsmith: (Default)
From: [personal profile] agoodwinsmith
Oh ... drat. Thank you.

April 2025

S M T W T F S
   1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23242526
27282930   

Most Popular Tags

Page Summary

Style Credit

Expand Cut Tags

No cut tags
Page generated Apr. 23rd, 2025 01:51 pm
Powered by Dreamwidth Studios